share_log

Biolase Said It Rejects Sonendo's "Patently Absurd" Claims

Biolase Said It Rejects Sonendo's "Patently Absurd" Claims

生物酶表示,它拒絕索嫩多的「明顯荒謬」的索賠
Benzinga Real-time News ·  2023/01/25 06:34

BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary PIPStek LLC (Sonendo), to use patent litigation to try to save Sonendo's diminished position and reputation in the marketplace.

BIOLASE, Inc. (NASDAQ: BIOL) 是世界領先的牙科雷射公司,今天發佈以下聲明,以回應索南多公司 (Sonendo) 的全資子公司 PipsTek LLC (Sonendo),利用專利訴訟試圖挽救索能多在市場上減少的地位和聲譽。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論